Abstract
Hematopoietic stem cell transplantation as a treatment for autoimmune disease began in 1996 and has subsequently spread worldwide. In Europe phase III trials have opened, while in America phase III trials are being designed and funded by the National Institutes of Health. On 6 June 2002, clinicians and scientists from around the world met at Snowbird, Utah to discuss the results and future directions of stem cell therapy for autoimmune diseases. What follows are general concepts from chairpersons of this meeting.
Original language | English (US) |
---|---|
Pages (from-to) | S3-S5 |
Journal | Bone Marrow Transplantation |
Volume | 32 |
DOIs | |
State | Published - Aug 2003 |
Externally published | Yes |
Keywords
- Autoimmune disease
- Stem cell transplantation
- Tissue regeneration
ASJC Scopus subject areas
- Hematology
- Transplantation